Eli Lilly Retained Earnings (Accumulated Deficit) 2010-2024 | LLY
Eli Lilly retained earnings (accumulated deficit) for the quarter ending June 30, 2024 were $13.178B, a 27.1% increase year-over-year.
- Eli Lilly retained earnings (accumulated deficit) for 2023 were $10.312B, a 2.69% increase from 2022.
- Eli Lilly retained earnings (accumulated deficit) for 2022 were $10.043B, a 12.1% increase from 2021.
- Eli Lilly retained earnings (accumulated deficit) for 2021 were $8.959B, a 14.41% increase from 2020.